BCR and B-cell chronic lymphocytic leukemia: Overall, mouse models represent a useful tool in studying the efficacy of alternative therapy options on the background of resistance-mutations found in CLL patients progressing under therapy and can be utilized to further dissect the BCR downstream signaling by evaluating a potential BTK bypass mechanism in the VLA-4 activation cascade.